Claims for Patent: 10,844,066
✉ Email this page to a colleague
Summary for Patent: 10,844,066
Title: | 2-amino-N-[7-methoxy-2, 3-dihydroimidazo-[1,2-c] quinazolin-5-yl] pyrimidine-5-carboxamides |
Abstract: | This invention relates to novel 2,3-dihydroimidazo[1,2-c]quinazoline compounds, pharmaceutical compositions containing such compounds and the use of those compounds or compositions for phosphotidylinositol-3-kinase (PI3K) inhibition and treating diseases associated with phosphotidylinositol-3-kinase (PI3K) activity, in particular treating hyper-proliferative and/or angiogenesis disorders, as a sole agent or in combination with other active ingredients. |
Inventor(s): | Schwarz Thomas, Liu Ningshu, Politz Oliver, Gerisch Michael, Lang Dieter |
Assignee: | Bayer Pharma Aktiengesellschaft |
Application Number: | US16082712 |
Patent Claims: |
Details for Patent 10,844,066
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Genzyme Corporation | THYROGEN | thyrotropin alfa | For Injection | 020898 | November 30, 1998 | 10,844,066 | 2037-03-01 |
Recordati Rare Diseases, Inc. | ELSPAR | asparaginase | For Injection | 101063 | January 10, 1978 | 10,844,066 | 2037-03-01 |
Amgen Inc. | EPOGEN/PROCRIT | epoetin alfa | Injection | 103234 | June 01, 1989 | 10,844,066 | 2037-03-01 |
Amgen Inc. | EPOGEN/PROCRIT | epoetin alfa | Injection | 103234 | 10,844,066 | 2037-03-01 | |
Amgen Inc. | PROCRIT | epoetin alfa | Injection | 103234 | 10,844,066 | 2037-03-01 | |
Iovance Biotherapeutics Manufacturing Llc | PROLEUKIN | aldesleukin | For Injection | 103293 | May 05, 1992 | 10,844,066 | 2037-03-01 |
Amgen Inc. | NEUPOGEN | filgrastim | Injection | 103353 | February 20, 1991 | 10,844,066 | 2037-03-01 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.